-+ 0.00%
-+ 0.00%
-+ 0.00%

X4 Pharmaceuticals secures up to $150 million senior debt facility with K2 HealthVentures

PUBT·10/08/2026 11:03:53
Listen to the news
X4 Pharmaceuticals secures up to $150 million senior debt facility with K2 HealthVentures
  • X4 Pharmaceuticals entered a senior secured term loan facility of up to USD 150 million with K2 HealthVentures.
  • USD 80 million funded at closing, used to repay all obligations under the prior loan, including USD 75 million principal.
  • Facility includes up to USD 70 million additional borrowing, subject to K2 HealthVentures approval and other conditions.
  • New facility extends financing runway with a longer interest-only period, 48-month maturity, supports potential mavorixafor launch preparations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080700PRIMZONEFULLFEED9841976) on October 08, 2026, and is solely responsible for the information contained therein.